Previous 10 | Next 10 |
2023-03-31 14:17:57 ET Shares of medical diagnostics company Lucid Diagnostics ( NASDAQ: LUCD ) rose ~6% on Friday after Medicare Administrative Contractor Palmetto GBA finalized Local Coverage Determination for molecular testing of certain upper gastrointestinal lesions. ...
Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer PR Newswire Foundational LCD, to be effective May 14, 2023 , incorporates key feedback to 2022 dr...
2023-03-14 02:15:32 ET Lucid Diagnostics press release ( NASDAQ: LUCD ): Q4 Non-GAAP EPS of -$0.15 beats by $0.17 . Revenue of $0.11M (-63.3% Y/Y) misses by $0.27M . 4Q22 and projected 1Q23 EsoGuard test volume increases 8 and 36 percent sequentially and 2...
Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial Results PR Newswire 4Q22 and projected 1Q23 EsoGuard ® test volume increases 8 and 36 percent sequentially and 288 and 300 percent annually. Company signs in-network agreement...
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , March 3, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid...
PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , March 3, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"...
PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes Live PR Newswire Remote patient monitoring of first cohort of cancer patients using VerisBox ™ connected devices and Veris CCP smartphone app initiated Cancer care team u...
Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event PR Newswire Partners with San Antonio Fire Department to test nearly 400 firefighters for esophageal precancer during Firefighter Cancer Awareness Month over two weekends, averaging nearly 100 tests p...
Strategic resource reallocation, including workforce reduction and other cost-cutting measures, to prioritize near-term Lucid and Veris Health commercialization efforts Conference call to be held today at 4:30PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a d...
Companies to host Conference Call at 4:30 PM EDT on Tuesday, January 17, 2023 PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lu...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Inc. Company Name:
LUCD Stock Symbol:
NASDAQ Market:
Lucid Diagnostics Inc. Website:
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...